Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Moderna a Buy?

TheMotleyFool

0 0

Is Moderna a Buy?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Biotech stocks have become more in demand than usual because of the coronavirus outbreak. With the need for a vaccine growing by the day, this unfortunate situation has given many vaccine developers the chance to make headlines. Moderna (NASDAQ: MRNA) is one of these companies. A $7.7 billion drug developer that specializes in messenger RNA (mRNA) vaccine treatments, the company caught quite a bit of attention back in late 2018 for being the biggest biotech IPO in history.

While there's plenty of interest surrounding this stock right now, what are its long-term prospects? Let's dive a bit deeper and see whether Moderna is truly worth a spot in your portfolio.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share